P/E at 65.79 vs Industry's 67.61: What the Data Shows for Max Healthcare Institute Ltd

Valuation Picture: Slight Discount to Industry Average

The current P/E of Max Healthcare Institute Ltd stands at 65.79, marginally below the hospital industry average of 67.61. This represents a modest valuation discount of approximately 2.7%, suggesting that the market is pricing the stock slightly more conservatively relative to its peers. Given the sector’s overall valuation level, this premium or discount can be indicative of investor sentiment towards the company’s earnings quality and growth prospects. However, the difference is not pronounced enough to signal a stark divergence in valuation. Max Healthcare Institute Ltd’s mid-cap market capitalisation of ₹98,496 crores places it solidly within the hospital sector’s competitive landscape.

Performance Across Timeframes: Mixed Momentum

Examining returns over various periods reveals a complex performance profile. Over the past year, Max Healthcare Institute Ltd has declined by 14.92%, considerably underperforming the Sensex’s 4.05% fall. This underperformance over the 12-month horizon contrasts with the stock’s more resilient shorter-term returns. For instance, the three-month return is a modest positive 1.10%, though still lagging the Sensex’s 2.17% gain. The one-month return is negative at -9.73%, underperforming the Sensex’s 0.88% rise, while the one-week return is a slight positive 0.74%, outperforming the Sensex’s marginal decline of 0.03%. This pattern suggests that while the stock has struggled over the longer term, recent price action has shown some signs of stabilisation or recovery — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Moving Average Configuration: Short-Term Strength Amid Longer-Term Weakness

The technical setup of Max Healthcare Institute Ltd further illustrates this mixed momentum. The stock is trading above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages. This configuration typically indicates a short-term bounce within a broader downtrend. The fact that the stock has been losing ground for two consecutive days, with a cumulative decline of 0.98%, adds to the cautionary tone. The opening price of ₹1005.05 has not been surpassed during the trading session, reflecting limited upward momentum. Such a setup often signals that while buyers have stepped in recently, the longer-term trend remains under pressure — is this a recovery or a dead-cat bounce?

Relative Performance vs Sensex: Underperformance Persists

Across multiple timeframes, Max Healthcare Institute Ltd has generally lagged the Sensex. The year-to-date return of -3.72% is better than the Sensex’s -9.04%, indicating some relative resilience in 2026 so far. However, the one-year underperformance of nearly 11 percentage points remains a concern. Over longer horizons, the stock has delivered strong absolute returns, with a three-year gain of 81.79% and a five-year gain of 200.40%, both substantially outperforming the Sensex’s respective 19.46% and 38.11% returns. This long-term outperformance contrasts with recent weakness, highlighting a shift in momentum. Should investors in Max Healthcare Institute Ltd hold, buy more, or reconsider?

Sector Context: Hospital Industry Performance

The hospital sector, within which Max Healthcare Institute Ltd operates, has seen mixed results recently. The industry P/E of 67.61 reflects relatively high valuations, consistent with the sector’s growth orientation and earnings potential. Sector performance has been varied, with some companies posting gains while others face headwinds from regulatory pressures and cost inflation. The sector’s overall trend has been cautious, with investors weighing growth prospects against margin pressures. Within this context, Max Healthcare Institute Ltd’s valuation and performance metrics suggest it is broadly in line with sector dynamics, though its recent underperformance relative to the Sensex and peers warrants attention.

Rating Context: Previously Rated Sell, Now Reassessed

MarketsMOJO had previously assigned a Sell rating to Max Healthcare Institute Ltd, but this was updated on 24 Jul 2026. The current Mojo Score stands at 50.0 with a Hold grade, reflecting a reassessment of the company’s prospects and risk profile. This change aligns with the mixed performance and valuation data, suggesting a more balanced view of the stock’s outlook. The rating update invites investors to reconsider their stance — what is the current rating?

Conclusion: A Stock at a Valuation Crossroads

The data for Max Healthcare Institute Ltd paints a picture of a stock trading at a valuation slightly below its hospital sector peers, with a mixed performance profile that combines long-term outperformance with recent underwhelming returns. The moving average configuration signals a short-term bounce within a longer-term downtrend, while the rating reassessment from Sell to Hold reflects a more balanced outlook. Investors face a nuanced scenario where valuation, momentum, and sector dynamics intersect — should investors in Max Healthcare Institute Ltd hold, buy more, or reconsider?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →